個別化細胞療法の世界市場レポート 2024年

個別化細胞療法市場規模は、今後数年間で飛躍的な成長が見込まれます。2028年にはCAGR22.5％で385億2,000万米ドルに成長します。予測期間の成長は、臨床検査の増加、慢性疾患の罹患率の上昇、高齢者の増加、がんの有病率の上昇、再生医療の採用増加などに起因すると考えられます。予測期間における主要動向には、技術の進歩、AIの統合、個別化ワクチン、バイオインフォマティクス、マイクロ流体技術などがあります。

神経疾患の増加は、今後の個別化細胞療法市場の成長を牽引すると予想されます。神経疾患は、脳、脊髄、神経に影響を与え、運動機能障害、認知障害、感覚障害などの症状を引き起こす疾患群です。神経疾患は、人口の高齢化、環境ストレス要因、神経変性疾患の罹患率上昇に寄与するライフスタイルの変化によって発生しています。個別化細胞療法は神経障害に必要であり、それは特定の患者のニーズに的を絞ったオーダーメイドの治療を提供し、損傷した神経組織を回復させ、複雑で個別化された状態の予後を改善する可能性があるからです。例えば、米国の政府機関であるパーキンソン財団によると、2022年12月、高齢者におけるパーキンソン病（PD）の年間発症率は、従来の推定値である6万例よりも50％増加するといいます。さらに、2030年までに120万人以上のアメリカ人がパーキンソン病を発症すると予測されています。したがって、神経疾患の増加が個別化細胞療法市場の成長を牽引しています。

個別化細胞療法市場で事業を展開する主要企業は、革新的な治療法の開発と商業化を加速するため、戦略的パートナーシップの形成に注力しています。これらの提携は、企業がリソース、専門知識、技術を結集して研究開発能力を強化し、臨床検査を合理化し、規制経路をより効率的にナビゲートするのに役立っています。例えば、米国のバイオテクノロジー企業であるCentury Therapeutics Inc.は、2022年10月、米国のバイオ医薬品企業であるBristol Myers Squibb（BMS）と、同種細胞療法の開発と商業化で提携しました。この提携は、センチュリーの革新的な人工多能性幹細胞（iPSC）技術を用いて、血液悪性腫瘍と固形腫瘍を治療するための人工天然キラー（NK）細胞療法とT細胞療法を創製するものです。本契約は、最大4つの異なる細胞療法プログラムの開発を包含し、当初は急性骨髄性白血病（AML）と多発性骨髄腫の2つの特定セグメントに焦点を当てる。これらのプログラムでは、iPS細胞由来の人工NK細胞やガンマ・デルタT細胞を利用します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界の個別化細胞療法市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の個別化細胞療法市場の実績：規模と成長、2018～2023年
• 世界の個別化細胞療法市場の予測：規模と成長、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の個別化細胞療法市場：細胞タイプ別、実績と予測、2018～2023年、2023～2028年、2033年
• リンパ球
• 間葉系幹細胞
• 造血幹細胞
• その他の細胞タイプ
• 世界の個別化細胞療法市場：技術別、実績と予測、2018～2023年、2023～2028年、2033年
• 血小板輸血
• 骨髄移植
• 赤血球輸血
• 臓器移植
• 世界の個別化細胞療法市場：用途別、実績と予測、2018～2023年、2023～2028年、2033年
• 心血管疾患
• 神経疾患
• 炎症性疾患
• 糖尿病
• がん
• その他
• 世界の個別化細胞療法市場：エンドユーザー別、実績と予測、2018～2023年、2023～2028年、2033年
• 病院
• 在宅医療
• 専門クリニック
• その他

第7章 地域別・国別分析

• 世界の個別化細胞療法市場：地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の個別化細胞療法市場：国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 個別化細胞療法市場：競合情勢
• 個別化細胞療法市場：企業プロファイル
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Gilead Sciences Inc.
  • Cipla Limited

第31章 その他の大手企業と革新的企業

• Poseida Therapeutics Inc.
• Sangamo Therapeutics Inc.
• Nkarta Therapeutics Inc.
• Intellia Therapeutics Inc.
• Tessa Therapeutics Pte Ltd
• Atara BIoTherapeutics Inc.
• Adaptimmune Therapeutics plc
• Precision BioSciences Inc.
• Editas Medicine Inc.
• Cellectis S.A.
• Gracell BIoTechnologies Inc.
• Mesoblast Limited
• Fate Therapeutics Inc.
• Athersys Inc.
• Bellicum Pharmaceuticals Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

Personalized cell therapy refers to a type of medical treatment where a patient's own cells, or cells that are specifically tailored to them, are used to treat a disease or condition. This therapy is customized to the individual's unique biological profile, often involving the modification or manipulation of cells to enhance their therapeutic potential. The key advantage of personalized cell therapy is that it minimizes the risk of rejection and adverse reactions as the therapy is designed to be compatible with the patient's own body.

The main types of personalized cell therapy include lymphocytes, mesenchymal stem cells, hematopoietic stem cells, and others. Lymphocytes are a type of white blood cell that are part of the immune system and help the body fight disease. It uses various techniques such as platelet transfusions, bone marrow transplantation, packed red cell transfusions, and organ transplantation and is applied for cardiovascular diseases, neurological disorders, inflammatory diseases, diabetes, cancer, and others. It is used by various end-users, including hospitals, homecare, specialty clinics, and others.

The personalized cell therapy market research report is one of a series of new reports from The Business Research Company that provides personalized cell therapy market statistics, including personalized cell therapy industry global market size, regional shares, competitors with a personalized cell therapy market share, detailed personalized cell therapy market segments, market trends and opportunities, and any further data you may need to thrive in the personalized cell therapy industry. This personalized cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The personalized cell therapy market size has grown exponentially in recent years. It will grow from $13.98 billion in 2023 to $17.11 billion in 2024 at a compound annual growth rate (CAGR) of 22.4%. The growth in the historic period can be attributed to increasing awareness of personalized medicine, increasing healthcare spending, increasing government initiatives, increasing funding for clinical research, rise in neurological disorders.

The personalized cell therapy market size is expected to see exponential growth in the next few years. It will grow to $38.52 billion in 2028 at a compound annual growth rate (CAGR) of 22.5%. The growth in the forecast period can be attributed to rising clinical trials, rising incidence of chronic illnesses, growing geriatric population, rising prevalence of cancer, and increasing adoption of regenerative medicines. Major trends in the forecast period include technological advancements, integration of AI, personalized vaccines, bioinformatics, and microfluidic technologies.

The rise in neurological disorders is expected to drive the growth of the personalized cell therapy market going forward. Neurological disorders are a group of conditions affecting the brain, spinal cord, and nerves, leading to symptoms such as impaired motor function, cognitive deficits, and sensory disturbances. Neurological disorders are occurring due to an aging population, environmental stressors, and lifestyle changes contributing to higher incidences of neurodegenerative diseases. Personalized cell therapy is required for neurological disorders as it offers tailored treatments that target specific patient needs, potentially restoring damaged neural tissue and improving outcomes in complex, individualized conditions. For instance, in December 2022, according to the Parkinson Foundation, a US-based government organization, the yearly incidence of Parkinson's disease (PD) among older persons is 50% greater than the existing estimate of 60,000 cases. Additionally, 1.2 million more Americans are predicted to have Parkinson's disease by 2030. Therefore, the rise in neurological disorders is driving the growth of the personalized cell therapy market.

Major companies operating in the personalized cell therapy market are focused on forming strategic partnerships to accelerate the development and commercialization of innovative therapies. These collaborations help companies pool resources, expertise, and technologies to enhance research and development capabilities, streamline clinical trials, and navigate regulatory pathways more efficiently. For instance, in October 2022, Century Therapeutics Inc., a US-based biotechnology company, partnered with Bristol Myers Squibb (BMS), a US-based biopharmaceutical company, to develop and commercialize allogeneic cell therapies. This collaboration uses Century's innovative induced pluripotent stem cell (iPSC) technology to create engineered natural killer (NK) and T cell therapies to treat hematologic malignancies and solid tumors. The agreement encompasses the development of up to four distinct cell therapy programs, with the initial focus on two specific areas, acute myeloid leukemia (AML) and multiple myeloma. These programs will utilize engineered NK cells or gamma delta T cells derived from iPSCs.

In April 2022, Fujifilm Corp., a Japan-based manufacturer of biopharmaceuticals, acquired a cell therapy manufacturing facility from Atara Biotherapeutics Inc. for USD 100 million. The key aims of the acquisition are to expand Fujifilm's CDMO capabilities in advanced therapies, strengthen its manufacturing capacity and expertise, and support Atara's clinical pipeline. Atara is a US-based allogeneic T-cell immunotherapy company.

Major companies operating in the personalized cell therapy market are AbbVie Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Gilead Sciences Inc., Cipla Limited, Poseida Therapeutics Inc., Sangamo Therapeutics Inc., Nkarta Therapeutics Inc., Intellia Therapeutics Inc., Tessa Therapeutics Pte Ltd, Atara Biotherapeutics Inc., Adaptimmune Therapeutics plc, Precision BioSciences Inc., Editas Medicine Inc., Cellectis S.A., Gracell Biotechnologies Inc., Mesoblast Limited, Fate Therapeutics Inc., Athersys Inc., Bellicum Pharmaceuticals Inc., Celyad Oncology SA, Century Therapeutics Inc., Gamida Cell Ltd., CRISPR Therapeutics AG, Allogene Therapeutics Inc.

North America was the largest region in the personalized cell therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cell therapy marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the personalized cell therapy marker report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized cell therapy market consists of revenues earned by entities by providing services such as c car-t cell therapy, stem cell transplantation, tissue regeneration, gene editing therapies and immunotherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized cell therapy market also includes sales of personalized cancer vaccines, cell therapy kits and related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Personalized Cell Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on personalized cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for personalized cell therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The personalized cell therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Cell Type: Lymphocytes; Mesenchymal Stem Cell; Hematopoietic Stem Cell; Other Cell Type
• 2) By Technique: Platelet Transfusions; Bone Marrow Transplantation; Packed Red Cell Transfusions; Organ Transplantation
• 3) By Application: Cardiovascular Diseases; Neurological Disorders; Inflammatory Diseases; Diabetes; Cancer; Other Applications
• 4) By End-User: Hospital; Homecare; Specialty Clinics; Other End-User
• Companies Mentioned: AbbVie Inc.; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Gilead Sciences Inc.; Cipla Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Personalized Cell Therapy Market Characteristics

3. Personalized Cell Therapy Market Trends And Strategies

4. Personalized Cell Therapy Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Personalized Cell Therapy Market Size and Growth

• 5.1. Global Personalized Cell Therapy Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Personalized Cell Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Personalized Cell Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Personalized Cell Therapy Market Segmentation

• 6.1. Global Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Lymphocytes
• Mesenchymal Stem Cell
• Hematopoietic Stem Cell
• Other Cell Type
• 6.2. Global Personalized Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Platelet Transfusions
• Bone Marrow Transplantation
• Packed Red Cell Transfusions
• Organ Transplantation
• 6.3. Global Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Cardiovascular Diseases
• Neurological Disorders
• Inflammatory Diseases
• Diabetes
• Cancer
• Other Applications
• 6.4. Global Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital
• Homecare
• Specialty Clinics
• Other End-User

7. Personalized Cell Therapy Market Regional And Country Analysis

• 7.1. Global Personalized Cell Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Personalized Cell Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Personalized Cell Therapy Market

• 8.1. Asia-Pacific Personalized Cell Therapy Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Personalized Cell Therapy Market

• 9.1. China Personalized Cell Therapy Market Overview
• 9.2. China Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Personalized Cell Therapy Market

• 10.1. India Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Personalized Cell Therapy Market

• 11.1. Japan Personalized Cell Therapy Market Overview
• 11.2. Japan Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Personalized Cell Therapy Market

• 12.1. Australia Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Personalized Cell Therapy Market

• 13.1. Indonesia Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Personalized Cell Therapy Market

• 14.1. South Korea Personalized Cell Therapy Market Overview
• 14.2. South Korea Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Personalized Cell Therapy Market

• 15.1. Western Europe Personalized Cell Therapy Market Overview
• 15.2. Western Europe Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Personalized Cell Therapy Market

• 16.1. UK Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Personalized Cell Therapy Market

• 17.1. Germany Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Personalized Cell Therapy Market

• 18.1. France Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Personalized Cell Therapy Market

• 19.1. Italy Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Personalized Cell Therapy Market

• 20.1. Spain Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Personalized Cell Therapy Market

• 21.1. Eastern Europe Personalized Cell Therapy Market Overview
• 21.2. Eastern Europe Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Personalized Cell Therapy Market

• 22.1. Russia Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Personalized Cell Therapy Market

• 23.1. North America Personalized Cell Therapy Market Overview
• 23.2. North America Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Personalized Cell Therapy Market

• 24.1. USA Personalized Cell Therapy Market Overview
• 24.2. USA Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Personalized Cell Therapy Market

• 25.1. Canada Personalized Cell Therapy Market Overview
• 25.2. Canada Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Personalized Cell Therapy Market

• 26.1. South America Personalized Cell Therapy Market Overview
• 26.2. South America Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Personalized Cell Therapy Market

• 27.1. Brazil Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Personalized Cell Therapy Market

• 28.1. Middle East Personalized Cell Therapy Market Overview
• 28.2. Middle East Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Personalized Cell Therapy Market

• 29.1. Africa Personalized Cell Therapy Market Overview
• 29.2. Africa Personalized Cell Therapy Market, Segmentation By Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Personalized Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Personalized Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Personalized Cell Therapy Market Competitive Landscape And Company Profiles

• 30.1. Personalized Cell Therapy Market Competitive Landscape
• 30.2. Personalized Cell Therapy Market Company Profiles
  • 30.2.1. AbbVie Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Bristol-Myers Squibb Company
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. GlaxoSmithKline plc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Gilead Sciences Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Cipla Limited
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Personalized Cell Therapy Market Other Major And Innovative Companies

• 31.1. Poseida Therapeutics Inc.
• 31.2. Sangamo Therapeutics Inc.
• 31.3. Nkarta Therapeutics Inc.
• 31.4. Intellia Therapeutics Inc.
• 31.5. Tessa Therapeutics Pte Ltd
• 31.6. Atara Biotherapeutics Inc.
• 31.7. Adaptimmune Therapeutics plc
• 31.8. Precision BioSciences Inc.
• 31.9. Editas Medicine Inc.
• 31.10. Cellectis S.A.
• 31.11. Gracell Biotechnologies Inc.
• 31.12. Mesoblast Limited
• 31.13. Fate Therapeutics Inc.
• 31.14. Athersys Inc.
• 31.15. Bellicum Pharmaceuticals Inc.

32. Global Personalized Cell Therapy Market Competitive Benchmarking

33. Global Personalized Cell Therapy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Personalized Cell Therapy Market

35. Personalized Cell Therapy Market Future Outlook and Potential Analysis

• 35.1 Personalized Cell Therapy Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Personalized Cell Therapy Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Personalized Cell Therapy Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer